Costs and Benefits in Health Care and Prevention

An International Approach to Priorities in Medicine

Häftad, Engelska, 1990

Av U. Laaser, E.J. Rocella, J.B. Rosenfeld, H. Wenzel, E. J. Rocella, J. B. Rosenfeld

1 449 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

One of the main purposes of medical cost-benefit analysis is to define the rational priorities in health care. This book undertakes a cost benefit analysis of three countries: the United States, Germany and Israel. Cardiovascular disease is examined in order to provide a model case study, but other areas also provide examples. The contributors consider in particular two recent developments: the increase in comprehensive epidemiological data, especially with regard to risk factors; and improved methodology for measuring the quality of life.

Produktinformation

Utgivningsdatum1990-09-07
Mått170 x 242 x 11 mm
Vikt326 g
FormatHäftad
SpråkEngelska
Antal sidor160
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783540527084

Tillhör följande kategorier

Medicin: allmänt inom Medicin
Hälso- och sjukvård inom Medicin

I Introduction.- Epidemiology and Economy, and the Appraisal of Human Life: Ethical and Practical Limitations of how to Value Health Benefits.- II Concepts.- Cost-Effectiveness Analysis, Cost-Benefit Analysis and the Value of Life in Health Care and Prevention.- Cost-Effectiveness Analysis in Health Care: Opportunities and Challenges to International Comparisons.- The Feasibility of Willingness-To-Pay Measurement in Health Services Research.- The Willingness-To-Pay Approach: Caveats to Biased Application.- III Experience.- 1. The Case of a Risk Factor: Hypertension.- Attitude and Behaviour of Stuttgart’s Primary Care Physicians with Regard to the Pharmacological and Non-Pharmacological Treatment of Mild Hypertension.- Comparisons of 1977 and 1987 Physician’s Knowledge Survey — Implications on Cost and Hypertension Management.- Evaluation of Cost-Effectiveness of Physician-Nurse Teams as Compared to Physicians Working alone in Primary Care Practices in Community Control of Hypertension.- The Ashkelon Hypertension Detection and Control Program: Medical and Cost Implications.- The Mangement of Hypertension: A Clinical Dilemma with Health Policy Implications.- 2. The Case of Clinical Disease.- Angina Pectoris Prophylaxis: A Model Estimate of Cost and Benefit.- Cost Considerations for the Management of End Stage Renal Disease in the United States.- Medical Treatment and its Implications on Costs. An Analysis with Process Data from the German Statutory Health Insurance.- IV The New Dimension: Quality of Life.- Quality of Life: Methodological Key Issues.- Towards the Integrated Measurement of Quality of Life.- Quality of Life, Clinical Trials, and Cost-Effectiveness Analysis: Conceptual Issues with Hypertension as an Example.- V Comments on the State of the Art.- Noteson Economic Evaluation.- Some Limitations in the Analysis of Costs and Benefits.- Research Perspectives for the Future: International Cooperation in Comparing Costs and Benefits of the Best Demonstrated Practice in Health Care and Prevention.